Autocrine motility factor secreted by HeLa cells inhibits the growth of many cancer cells by regulating AKT/ERK signaling
- 1 May 2020
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 525 (3) , 557-562
Abstract
No abstract availableKeywords
Funding Information
- Catholic University of Daegu (20177027)
This publication has 29 references indexed in Scilit:
- Competitive cell interactions in cancer: a cellular tug of warTrends in Cell Biology, 2013
- The Hippo Signaling Pathway in Development and CancerDevelopmental Cell, 2010
- The complex biology of autocrine motility factor/phosphoglucose isomerase (AMF/PGI) and its receptor, the gp78/AMFR E3 ubiquitin ligaseMolecular BioSystems, 2009
- Switching Akt: from survival signaling to deadly responseBioEssays, 2009
- Raft-Dependent Endocytosis of Autocrine Motility Factor/Phosphoglucose Isomerase: A Potential Drug Delivery Route for Tumor CellsPLOS ONE, 2008
- Occurrence of cancer at multiple sites: Towards distinguishing multigenesis from metastasisBiology Direct, 2008
- Soluble factors mediate competitive and cooperative interactions between cells expressing different levels of Drosophila MycProceedings of the National Academy of Sciences, 2007
- Cancer Cell Biology: Myc Wins the CompetitionCurrent Biology, 2004
- Drosophila Myc Regulates Organ Size by Inducing Cell CompetitionCell, 2004
- Inhibition Mechanism of Cytokine Activity of Human Autocrine Motility Factor Examined by Crystal Structure Analyses and Site-directed Mutagenesis StudiesJournal of Molecular Biology, 2002